(20:02 GMT) Taysha Gene Therapies Price Target Maintained With a $12.00/Share by Needham
DO Dow Jones Newswires Taysha Gene Therapies Is Maintained at Buy by Needham 7/1/2026, 04:02 AM GMT+8 Dow Jones Newswires TS TSHA (20:02 GMT) Taysha Gene Therapies Price Target Maintained With a $12.00/Share by Needham Market News Dow Jones Newswires Taysha Gene Therapies Price Target Maintained With a $11.00/Share by Citizens Dow Jones Newswires Taysha Gene Therapies Is Maintained at Outperform by Baird TradingView Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13, Implies 105% Upside
